Top 50 Biotech Angel Investors in United States (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Milad Alucozai
Angel
|
20 | United States, Canada, United Kingdom | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Artificial Intelligence | $110k–$60M |
|
Sahin Boydas
Angel
|
14 | United States, Mexico, Norway | Seed, Series A, Series B | Software, Financial Services, Information Technology | $500k–$150M |
|
Christopher Gibson
Angel
|
14 | United States, United Kingdom, France | Series A, Seed, Series B | Biotechnology, Health Care, Pharmaceutical | $5.4M–$55M |
|
Jeff Dean
Angel
|
13 | United States, United Kingdom, Japan | Seed, Series A, Pre-Seed | Artificial Intelligence, Information Technology, Software | $450k–$60M |
|
Sam Altman
Angel
|
11 | United States, Canada, Ghana | Seed, Series A, Series B | Software, Artificial Intelligence, Biotechnology | $1.2M–$100M |
|
Jaffray Woodriff
Angel
|
10 | United States | Seed, Series A, Angel | Software, Biotechnology, Health Care | $250k–$11M |
|
Farzad Nazem
Angel
|
9 | United States, Canada | Seed, Series A, Series B | Health Care, Software, Analytics | $750k–$50M |
|
Kingsley Advani
Angel
|
9 | United States, Singapore, United Kingdom | Seed, Pre-Seed, Series A | FinTech, Financial Services, Biotechnology | $120k–$183M |
|
Jude Gomila
Angel
|
9 | United States, United Kingdom, India | Seed, Pre-Seed, Angel | Software, Information Technology, Biotechnology | $70k–$5M |
|
bumpkins profile
Angel
|
8 | United States, Canada, India | Seed, Series A, Pre-Seed | Health Care, Biotechnology, Medical | $500k–$57M |
|
Dimitri Seas
Angel
|
8 | United States, Hong Kong, United Kingdom | Seed, Pre-Seed, Series A | Robotics, Health Care, Artificial Intelligence | $365k–$4.2M |
|
Alice Zhang
Angel
|
8 | United States, United Kingdom | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Therapeutics | $120k–$30M |
|
Paul Buchheit
Angel
|
8 | United States, Canada, India | Seed, Series A, Angel | Software, Artificial Intelligence, E-Commerce | $100k–$14M |
|
Balaji Srinivasan
Angel
|
7 | United States, India, Singapore | Seed, Pre-Seed, Series A | Blockchain, Cryptocurrency, Software | $450k–$28M |
|
Jeff Hammerbacher
Angel
|
7 | United States, Germany | Seed, Series A, Angel | Artificial Intelligence, Software, Biotechnology | $330k–$25M |
|
Wei Guo
Angel
|
6 | United States, China, Canada | Seed, Series A, Angel | Software, Artificial Intelligence, Internet | $200k–$19M |
|
Kevin Moore
Angel
|
6 | United States, India, Canada | Seed, Pre-Seed, Angel | Software, Health Care, E-Commerce | $190k–$5.2M |
|
Jim Mellon
Angel
|
6 | United States, United Kingdom, Israel | Series A, Seed | Biotechnology, Food and Beverage, Health Care | $536k–$47M |
|
John Ballantyne
Angel
|
6 | United States, Singapore | Seed, Series A, Angel | Health Care, Biotechnology, Therapeutics | $4.5M–$30M |
|
Rand Hindi
Angel
|
6 | France, United States, Germany | Seed, Pre-Seed | Cryptocurrency, Software, Machine Learning | $125k–$11M |
|
Zach Weinberg
Angel
|
6 | United States, Israel, United Kingdom | Seed, Series A, Pre-Seed | Software, Health Care, Medical | $1.4M–$30M |
|
Maxim Basov
Angel
|
5 | Russian Federation, United States | Seed, Angel, Pre-Seed | Health Care, Apps, Legal | $775k–$1.1M |
|
Chris Gibson
Angel
|
5 | United States, France, Switzerland | Series A, Seed | Biotechnology, Health Care, Life Science | $4.9M–$55M |
|
Daniel Schryer
Angel
|
5 | United States, India, Panama | Seed, Series B, Angel | Software, Internet, Mobile | $25k–$50M |
|
Elad Gil
Angel
|
5 | United States, United Kingdom, Israel | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $2M–$117M |
|
Peter Thiel
Angel
|
5 | United States, Germany, Canada | Series A, Seed, Series B | Software, FinTech, Financial Services | $900k–$116M |
|
Thomas Tull
Angel
|
5 | United States | Series A, Series C, Series B | Artificial Intelligence, Software, Machine Learning | $12M–$320M |
|
Daniel Curran
Angel
|
5 | United States, Canada, Brazil | Seed, Series A, Series B | E-Commerce, Software, Internet | $600k–$50M |
|
Brian Armstrong
Angel
|
5 | United States, Brazil, Libya | Seed, Series A, Series B | Biotechnology, Payments, Financial Services | $2M–$130M |
|
Evan Cheng
Angel
|
5 | United States, United Kingdom, Australia | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Biotechnology | $120k–$18M |
|
Bill Gates
Angel
|
5 | United States, Canada, Israel | Series C, Series A, Series B | Energy, Biotechnology, Renewable Energy | $12M–$161M |
|
Anne Wojcicki
Angel
|
5 | United States, United Kingdom, Canada | Seed, Series A, Series B | Health Care, Medical, Biotechnology | $1M–$70M |
|
Mark Cuban
Angel
|
5 | United States, United Kingdom, Canada | Seed, Series A | Software, Artificial Intelligence, Blockchain | $600k–$23M |
|
Fred Ehrsam
Angel
|
5 | United States, Canada, Israel | Seed, Series A, Series C | Blockchain, Cryptocurrency, Software | $1M–$300M |
|
Benjamin Kong
Angel
|
5 | United States, Israel, United Kingdom | Seed, Pre-Seed | Biotechnology, Blockchain, Cryptocurrency | $750k–$8.7M |
|
Edward Lando
Angel
|
5 | United States, United Kingdom, France | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, FinTech | $125k–$37M |
|
Erik Peterson
Angel
|
5 | United States, Canada, Algeria | Seed, Equity Crowdfunding, Series A | Software, SaaS, Mobile | $69k–$20M |
|
Darian Shirazi
Angel
|
4 | United States, Germany, Canada | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $2M–$73M |
|
Alec Nielsen
Angel
|
4 | United States, Germany | Seed, Pre-Seed | Biotechnology, Biopharma, Medical | $3M–$16M |
|
Cory Levy
Angel
|
4 | United States, Canada, United Kingdom | Pre-Seed, Seed, Series A | Artificial Intelligence, Software, Advertising | $200k–$72M |
|
Eric Kwan
Angel
|
4 | United States, India, Canada | Seed, Pre-Seed | Software, FinTech, E-Commerce | $125k–$9.5M |
|
Jack Abraham
Angel
|
4 | United States, France, Hong Kong | Seed, Series A, Series B | Health Care, Software, Financial Services | $1.2M–$100M |
|
John D'Orazio
Angel
|
4 | United States | Seed, Equity Crowdfunding | Medical, Health Care, Biotechnology | $245k–$1.3M |
|
Todd Corenson
Angel
|
4 | United States | Seed, Pre-Seed, Convertible Note | Biotechnology, FinTech, SaaS | $1M–$4.4M |
|
Esther Dyson
Angel
|
4 | United States, Canada, Russian Federation | Seed, Series A | Health Care, Software, Medical | $270k–$16M |
|
Timothy A. Springer
Angel
|
4 | United States, Canada | Series A, Series B, Post-IPO Equity | Biotechnology, Medical, Health Care | $15M–$130M |
|
Bradley Horowitz
Angel
|
4 | United States, United Kingdom, Germany | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $150k–$120M |
|
Nat Turner
Angel
|
4 | United States, China, Colombia | Seed, Series A, Series B | Health Care, Software, Medical | $1.5M–$36M |
|
David Beyer
Angel
|
4 | United States | Seed, Series A, Angel | Software, Artificial Intelligence, Machine Learning | $500k–$23M |
|
Max Levchin
Angel
|
4 | United States, United Kingdom, India | Seed, Series A, Series B | FinTech, Financial Services, Software | $1.3M–$50M |
| Access all 1557 angel investors in United States Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 55
- Round size: Seed $1M–$7M; Pre-Seed $110k–$5M; Series A $13M–$60M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
- Revalia Bio — Revalia Bio develops curative drugs for chronic organ-centered disease.
- Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Sahin Boydas is the PEF Chapter Lead of PEF Community. He previously worked at RemoteTeam.com as CEO and Founder. Sahin Boydas attended Koç University, where he took a Bachelor of Science in Computer Engineering, and Bahcesehir University, where he took a Master of Business Administration in Entrepreneurship.
Show more...Investment focus
- Industry: Software, Financial Services, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Mexico, Norway
Investor stats
- Total investments: 276
- Round size: Seed $500k–$15M; Series A $7M–$36M; Series B $23M–$150M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Seezo — Security design reviews for every feature your company builds. Someday, we will be more active on Twitter
- Neurable — Neurable is a neurotechnology company specializing in developing AI-powered tools for brain signal translation and brain-computer interface technology. Utilizing patented signal processing, developed through research across labs and institutions, and advanced by a scientific and expert product team, its platform enables high-performancebrain-computer interface in everyday devices.
- Normal Computing — Normal Computing was founded by former members of the Google Brain Team, Palantir, and X who unlocked AI for some of the largest-scale and most mission-critical production systems, and the industry leading ML frameworks for Probabilistic and Quantum AI.
Christopher Gibson is based out of Salt Lake City, Utah, and is the Interim Executive Advisor, Co-Founder and Chairman of the Board of Directors of Recursion Pharmaceuticals. Christopher previously worked at Cure Hereditary Hemorrhagic Telangiectasia as a Member of the Board of Directors. Christopher Gibson attended the University of Utah.Christopher Gibson has been awarded the 2013 TEDMED Front Line Scholar.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 25
- Round size: Seed $5.4M–$14M; Series A $12M–$55M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Zanskar — Zanskar Geothermal & Minerals uses custom AI tools and geoscience models to analyze vast amounts of data and pinpoint untapped geothermal hotspots.
- Play Health — Delivering data & AI-driven (peri)menopause care software to improve outcomes today, developing precision medicine infrastructure for tomorrow.
- Dunia Innovation — Catalysing the energy transition.
Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.
Show more...Investment focus
- Industry: Artificial Intelligence, Information Technology, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Japan
Investor stats
- Total investments: 104
- Round size: Seed $2.5M–$35M; Pre-Seed $450k–$2.3M; Series A $10M–$60M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Moonlake AI — Vibe code games and worlds into existence.
- Belfort — Enabling Fully Homomorphic Encryption through Hardware Acceleration
- Periodic Labs — From bits to atoms.
Sam Altman is the CEO and co-founder of OpenAI. He is a Partner of Apollo Projects. Altman was the president of Y Combinator. Sam attended Stanford University.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Ghana
Investor stats
- Total investments: 186
- Round size: Seed $1.2M–$10M; Series A $10M–$50M; Series B $17M–$100M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Exowatt — Modular full-stack renewable energy solutions for commercial and industrial customers.
- Preventive — Preventive mission is to determine whether the newest generation of gene editing technologies can be used safely and responsibly to correct devastating genetic conditions for future children.
- Red Queen Bio — Red Queen Bio is an AI biosecurity company. Think of us as the cybersecurity layer for biology. AI is making it dramatically easier to design powerful new drugs and therapies, which is extraordinary news for medicine. But the same tools are also lowering the barrier for bad actors to engineer dangerous pathogens, and opening up an entirely new category of threats, including viruses designed to evade human immunity.Defense has to keep pace with offense.
Angel Investor located in Charlottesville, VA
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A, Angel
- Geography: United States
Investor stats
- Total investments: 47
- Round size: Seed $640k–$4.3M; Angel $250k–$2.6M; Series A $3.4M–$11M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Yogi — Yogi's analytics platform lets you easily sift through customer Reviews & Ratings data. Get actionable insights from your product Reviews, Ratings, and Sentiment Analysis to improve your brand reputation and product experiences.
- Caju AI — Caju AI revolutionizes customer engagement with Generative AI, boosting your workforce's productivity and providing invaluable business insights. Elevate your customer experience with the power of AI.
- Starchive — AI enriched Digital Asset Management designed by creators for creators, to maximize the control and ownership of their content, community, and commerce in the Visual Media Economy.
Farzad (Zod) Nazem has been a prolific angel investor and advisor to tech startup companies since his retirement from Yahoo! in 2007. He has invested in more than 60 early stage companies, and sits on the boards of Hand Foundation, and The Nueva School. His area of investment is about two thirds Big Data and Cloud platforms, and one third Healthand Medical. He was the Executive Vice President of Engineering and Chief Technology Officer of Yahoo from 1996 to mid 2007. He helped acquire and integrate over 50 companies and managed over six thousand engineers representing half of the company's employees. Between 1985 and 1996, Mr. Nazem held various software development and management positions at Oracle Corporation culminating in his role as Vice President of Media and Web Server Division. His tenure at Oracle also included membership in the company's Product Division Management Committee, which set overall strategy for Oracle products. Previously, Mr. Nazem was recruited from California Polytechnic State University by Rolm Corporation to be a software engineer in the VLCBX division. At age 19, he earned a B.S. degree in Computer Science with highest honors.
Show more...Investment focus
- Industry: Health Care, Software, Analytics
- Stage:Seed, Series A, Series B
- Geography: United States, Canada
Investor stats
- Total investments: 64
- Round size: Seed $750k–$6.5M; Series A $2.8M–$14M; Series B $6M–$50M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Emailage — Emailage is a developer of fraud prevention and identity verification technology used to make transactions easier and secure. The company provides multi-faceted predictive solutions with email at the core through key partnerships, proprietary data, and advanced machine-learning technology. It proprietary algorithms in order to provide real-timealerts of risky transactions and delivers a risk score and enable companies to realize significant savings from identifying and stopping fraudulent transactions and improve customer experience.
- Ceevra — Ceevra is an advanced 3D visualization technology for surgeons. Using AI and other innovative computing techniques, Ceevra generates brilliant 3D digital models from standard CT scans and MRIs. Surgeons use the Ceevra 3D models to help educate and counsel patients, to decide on the best surgical approach, and to gain important insights whileoperating.
- TigerGraph — TigerGraph is the leading graph database for real-time AI and analytics. Detect fraud, resolve entities, and uncover hidden connections at enterprise scale.
Kingsley Advani (born October 24, 1993, in London, United Kingdom) is a British tech entrepreneur, investor, and author based in Dubai, United Arab Emirates. He is the Founder and CEO of Allo, an exchange for tokenized stocks managing over $2 billion in tokenized real-world assets, and the founder of Allocations, a fintech platform that has grownto administer more than $2 billion in assets across 30,000+ high-net-worth clients.Advani began his entrepreneurial journey at the age of 13, launching a digital commerce business on eBay, before discovering Bitcoin in 2011 while studying finance and economics. In 2013, he allocated his IBM internship savings into Bitcoin and other emerging cryptocurrencies, becoming an early investor in what later became a multi-billion-dollar asset class. By his mid-twenties, he had invested in more than 200 companies, including unicorns such as SpaceX, Solana, Coinbase, Robinhood, and eToro.In 2017, he co-founded a global investor syndicate that collectively managed more than $4 billion in assets. Two years later, he launched Allocations, a platform providing infrastructure for fund administration, SPVs, and private market investments. CNBC recognized him as the “Blockchain Oracle” for his early insights into cryptocurrency adoption and market trends.Through his ventures, Advani has become a leading voice in fintech, blockchain, tokenization, private markets, and Web3, with frequent speaking engagements at global conferences including the SF Blockchain Summit, Beyond Blocks, Coinfest Asia, and the Ritossa Summit in Dubai. His commentary emphasizes how blockchain and emerging technologies can democratize access to alternative assets and reduce the barriers to launching micro-funds.Advani is also the author of The Blockchain Oracle: How Technology, Finance, and Vision Shape the Future of Global Investing (2025), a book that explores the intersection of blockchain, fintech, and global finance.
Show more...Investment focus
- Industry: FinTech, Financial Services, Biotechnology
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Singapore, United Kingdom
Investor stats
- Total investments: 45
- Round size: Seed $120k–$4.3M; Pre-Seed $120k–$4.5M; Series A $4M–$183M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- OncoSenX — OncoSenX is a developer of transient gene therapies designed for solid tumors. The company's therapy delivers plasmid DNA with a novel lipid nanoparticle that selectively kills cancerous cells based on their transcriptional activity, providing cancer patients, doctors and medical care professionals with a less invasive and more preciseintervention for this complex and devastating disease.
- Checkstep — CheckStep provides a AI-powered Trust & Safety and UGC management software to online platform worldwide. It enables company to manage the full policy management life-cycle.
- Allocations — 10,000+ investors and fund managers build, onboard and close funds on Allocations - the fastest and most advanced fund platform in the world
Jude Gomila is currently CEO and Founder of the startup Golden.
Show more...Investment focus
- Industry: Software, Information Technology, Biotechnology
- Stage:Seed, Pre-Seed, Angel
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 64
- Round size: Seed $1.4M–$5M; Angel $70k–$1.3M; Pre-Seed $660k–$2.9M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Vaire — Conventional chips waste all their energy as heat. Vaire's groundbreaking technology will recover and recycle most of its energy, delivering low energy, high performance compute for the AI era.
- Clara — Clara is an AI-powered primary care doctor.
- Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, India
Investor stats
- Total investments: 49
- Round size: Seed $2.3M–$9.1M; Pre-Seed $500k–$2M; Series A $10M–$57M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
- Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
- Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!The founder of 2GIS
Show more...Investment focus
- Industry: Robotics, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Hong Kong, United Kingdom
Investor stats
- Total investments: 13
- Round size: Seed $600k–$4.2M; Pre-Seed $365k–$1.1M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- Stafory (Robot Vera) — Stafory is the first service created for employers and HR-agencies in Russia and the creator of Robot Vera - the robot-recruiter. In three hours it goes through the whole chain of the hiring process, finds the best candidates for a job, and invites them to the final interview with the employer. Vera is multitasking, professional and can workanywhere in the world. Our goal is to simplity the process of searching a reliable partner in the field of recruitment, and allow recruitment agencies to have access to an unlimited amount of employers' applications for recruitment services
- Welltory — Your personal data analyzed and transformed into powerful insights that keep you on track for lifelong health
- Dodo Brands — DODO Brands build disruptive QSR brands powered by tech and scale them through franchising.
CEO and Co-founder at Verge Genomics; Angel Investor in Tech-Enabled Bio
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom
Investor stats
- Total investments: 15
- Round size: Seed $120k–$5.9M; Series A $12M–$30M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Encellin — Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes. It was founded in 2016 and is headquartered in San Francisco, California.
- Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
- Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
Paul Buchheit is based out of Mountain View, California and is the Co-Founder and General Partner of Standard Capital. Paul Buchheit attended Case Western Reserve University.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, E-Commerce
- Stage:Seed, Series A, Angel
- Geography: United States, Canada, India
Investor stats
- Total investments: 153
- Round size: Seed $1.1M–$5M; Angel $100k–$1.6M; Series A $2.5M–$14M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- SiPhox Health — Painless, 5-minute biomarker testing at home. Clear insights, trend tracking, and a personalized plan built around your results.
- BuildForever — BuildForever build products that feel personal, magical and deeply human.
- Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including anonline MOOC.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, India, Singapore
Investor stats
- Total investments: 271
- Round size: Seed $2.3M–$15M; Pre-Seed $450k–$4.2M; Series A $6M–$28M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Vorflux — Cloud agents that ship production code. An opinionated harness that runs the full SDLC on dedicated machines.
- BizScout — BizScout is an online platform of Off market deals for verified buyers and sellers.
- Warp — Warp is a payroll and compliance tool that makes it easy for founders to hire, onboard, and pay their employees.
Jeff Hammerbacher - Partner & Co-Founder @ Techammer
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Biotechnology
- Stage:Seed, Series A, Angel
- Geography: United States, Germany
Investor stats
- Total investments: 33
- Round size: Seed $1M–$20M; Angel $330k–$330k; Series A $3M–$25M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Lamin — Open data platform for traceable multimodal AI. Query, trace, and govern data with a lineage-native lakehouse for files, tables, arrays, ontologies, and notes.
- Ridge AI — Ridge AI makes it fast and easy for SaaS companies to prove value inside their product.
- United Manufacturing Hub — The United Manufacturing Hub is an Open-Source Industrial IoT Infrastructure Platform enabling to easily connect, configure, manage, and maintain their factory.
Wei Guo, the founding partner of UpHonest Capital, is an active angel investor in Silicon Valley, focusing on early-stage cross-sector investments. He founded Wei Fund in 2015 and UpHonest Capital Fund I in 2016, invested in well-known companies such as Hims&Hers(NYSE: HIMS), Vicarious Surgical(NYSE: RBOT), Knightscope (NASDAQ: KSCP), Checkr,Lime, Boom, Rescale, Dialpad and more. Since 2015, he has invested in over 400 Silicon Valley startups, over 76 companies with valuations greater than 100 million USD, and 23 portfolio companies that have successfully exited.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Internet
- Stage:Seed, Series A, Angel
- Geography: United States, China, Canada
Investor stats
- Total investments: 155
- Round size: Seed $200k–$4.3M; Angel $375k–$10M; Series A $7M–$19M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- tbh — tbh is a developer of a mobile application designed to provide anonymous feedback to friends. The company's mobile application facilitates asking or answering questions, open text fields and invite abuse when combined with anonymity, enabling users to say things without repercussions and feel better about themselves from the positive feedbackon social networks.
- Golden — Golden is a developer of a self-constructing knowledge database used to accelerate discovery and education. The company uses and leverages human effort by using machine intelligence to make the process of gathering and communicating knowledge simpler.It combines a powerful search across several entities with fine-grain alerts to stay on top ofchanges, and semi-automatic research assistance for gaps in knowledge that enable people in organizations to stay current, understand and leverage the latest trends in their industry.
- Crossing — Crossing Media is a live broadcast e-commerce service company that builds awareness, engagement, and sales through live-stream shopping.
Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Pre-Seed, Angel
- Geography: United States, India, Canada
Investor stats
- Total investments: 101
- Round size: Seed $190k–$5.2M; Pre-Seed $800k–$2.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
- Trace — Trace is an orchestration engine that breaks down existing workflows, assigns repetitive tasks to AI agents and routes the rest to the right people.
- Augmend — Create documentation and an AI assistant from any video.
Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Health Care
- Stage:Series A, Seed
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 32
- Round size: Seed $536k–$20M; Series A $4.6M–$47M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- Netwealth — Netwealth provides expert investment management and tailored wealth planning solutions, helping you confidently achieve your financial goals.
- Juvenescence — We extend healthy lifespan through developing innovative medicines that target core aging mechanisms to not only treat but prevent age-related diseases.
- Repair Biotechnologies — Repair Biotechnologies is a developer of clinical gene and protein therapies intended to focus on the reversal of age-associated thymic atrophy and consequent loss of immune function. The company's platform is committed to developing treatments for ageing and age-related diseases that address the root causes of these conditions, enabling humanbeings to improve their health span through targeting the causes of age-related diseases and ageing itself.
John Ballantyne is a founder of Agathos Biologics. He co-founded Aldevron with Michael Chambers in 1998 and has been the Chief Scientific Officer since its establishment. His innovative work at Aldevron includes creation of the GMP Source product line and collaborative research with military scientists in the development of vaccine andpassive-based countermeasures to lethal and potentially weaponized viral hemorrhagic threats such as Ebola, Marburg and some hantavirus family members. He leads the research and development team at Aldevron which develops new methods and products through internal programs, collaborations, and technology licensing. John sees the advances in biotechnology providing opportunities for Agathos to enable ethical pharmaceutical development that will benefit patients, employees, and society. Ballantyne received undergraduate degrees in Pharmacy from the Central Institute of Technology and the University of Otago in New Zealand. After beginning graduate school in New Zealand he transferred to the United States in 1994 and completed his Ph.D. in Pharmaceutical Sciences at North Dakota State University.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Seed, Series A, Angel
- Geography: United States, Singapore
Investor stats
- Total investments: 11
- Round size: Seed $4.5M–$7M; Series A $12M–$30M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
- SmartWorx — Enterprise no-code platform. Build governed, AI-powered enterprise applications without writing a single line of code. Not bolted on. Built in.
- GlucoTrack — GlucoTrack is a medical device manufacturing company that specializes in developing a non-invasive glucose monitoring devices. It has developed a medical device that measures glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic.
Rand Hindi is based out of United States and is the General Partner of Unit Ventures. Rand previously worked at Naval Group as an Advisor. Rand Hindi attended Singularity University. Rand Hindi has been awarded Rising Star.
Show more...Investment focus
- Industry: Cryptocurrency, Software, Machine Learning
- Stage:Seed, Pre-Seed
- Geography: France, United States, Germany
Investor stats
- Total investments: 40
- Round size: Seed $2.6M–$11M; Pre-Seed $125k–$3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Usual — Usual Labs operates as a decentralized finance(DeFi) protocol.
- Optimum — The Universal Data Acceleration Network | Powered by RLNC
- Brink Therapeutics — Brink Therapeutics is a Biotechnology Research firm conducting cell therapy research using reprogrammed recombinases.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 72
- Round size: Seed $1.4M–$7.6M; Pre-Seed $1.5M–$2.3M; Series A $3M–$30M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Scoop — Thrive in a hybrid work environment with Scoop's solutions for Workplace Safety, Workplace Utilization, Team Coordination, Desk Management, and Commute.
- Crosby — The AI Law Firm Built for Execution. Lawyer-assisted AI to review MSAs, DPAs and NDAs in under an hour.
- Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.
Maxim Basov
Show more...Investment focus
- Industry: Health Care, Apps, Legal
- Stage:Seed, Angel, Pre-Seed
- Geography: Russian Federation, United States
Investor stats
- Total investments: 10
- Round size: Seed $775k–$1.1M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- Welltory — Your personal data analyzed and transformed into powerful insights that keep you on track for lifelong health
- Elementaree — Elementaree makes food personal every day and delivers it on a subscription basis to the doorstep. We create personal food programs catered to particular needs and goals whether it’s about losing weight, creating tasty meals for your family or increasing your body muscles. Unique personalized programs at cost of a standard grocery check. We adoptour expertise in building value chains which allows us to customize at scale. A never-repeating variety of everyday menus and personalized add-ons catered to customers' specific needs.
- Synchronization — Synchronization is an online course for music, philosophy, fashion and design, architecture, art, psychology, special projects, master classes, and cinema. They provide biology and a healthy lifestyle, film history, and film language.
Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Seed
- Geography: United States, France, Switzerland
Investor stats
- Total investments: 10
- Round size: Seed $4.9M–$14M; Series A $6.3M–$55M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Amenities Health — Amenities is the healthcare industry's leading Digital Front Door and patient loyalty platform. We help healthcare providers to acquire new patients and upgrade them to members. Our all-in-one patient app works with most modern EMRs to: 1) register new users into a full EMR account in <30 seconds with full identity verification and noduplicates, 2) help those patients find care options and book appointments with simple, conversion-optimized workflows, 3) seamlessly integrates key patient portal and 3rd party functions (i.e., video visits, secure messaging, test results, and billing), and 4) upgrade patients to members with custom experiences and services offerings (i.e., for Medicare Advantage, concierge memberships, direct-to-employer, or direct primary care patients)
- Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
- Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
Dan Schryer was formerly CEO of DCI Data Centers, a Blackstone backed technology real estate company. Together with Guru Gowrappan, formerly CEO of Verizon Media, he co-founded Bali Venture Partners, LLC to invest in seed and growth stage debt and equity opportunities.
Show more...Investment focus
- Industry: Software, Internet, Mobile
- Stage:Seed, Series B, Angel
- Geography: United States, India, Panama
Investor stats
- Total investments: 35
- Round size: Seed $25k–$1M; Angel $75k–$670k; Series B $150k–$50M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- 54gene — 54gene is a healthcare startup unlocking the African genome to fuel genetic research and development that may lead to new discoveries and benefit all populations.54gene was founded in 2019 by Dr. Abasi Ene-Obong to address the significant gap in the global genomics market: Nearly 90% of genetic material used in pharmaceutical research iscaucasian. Only 2% is African, despite the fact that Africans and people of African ancestry are more genetically diverse than all other world populations combined. As a result, pharmaceutical research and development is lacking the diverse data that may hold the key to medical discoveries and new healthcare solutions.
- Betterhalf — Best matrimony app in India with AI matchmaking. Get compatible life partner from lakhs of genuine, Govt ID and selfie verified profiles of brides & grooms. Download Betterhalf marriage app now!
- SOS Hydration — Rescue yourself from dehydration with SOS, doctor formulated rapid hydration with 80x less sugar than sports drinks and only 3g carbs and 10 calories.
Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 259
- Round size: Seed $2M–$17M; Series A $9.5M–$50M; Series B $27M–$117M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- NavigateAI — An AI copilot for every person in the field. NavigateAI upskills and coaches your team, runs real-time quality control, manages the project in the background, and provides expert knowledge, instantly.
- Harvey — Harvey is an artificial intelligence technology service provider.
- Socket — Socket fights vulnerabilities and provides visibility, defense-in-depth, and proactive supply chain protection for JavaScript, Python, and Go dependencies.
Peter Thiel Is the Managing Partner of The Founders Fund. He previously worked at Stanford Law School as a Visitor. Peter Thiel attended Stanford University.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Series A, Seed, Series B
- Geography: United States, Germany, Canada
Investor stats
- Total investments: 233
- Round size: Seed $900k–$10M; Series A $3M–$32M; Series B $16M–$116M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Objection — Objection.ai is a new AI‑driven platform positioned as an “AI judge” for contested claims in journalism and public‑sphere reporting.
- Panthalassa — We're harnessing renewable energy in the open ocean and delivering it around the world. Engineered in Portland, Oregon.
- Reserve — Reserve is a universal currency company. Reserve provides people with hyperinflation protected savings accounts to protect and use their money globally. They offer rtokens, collateral baskets, and over collateralization.
Thomas Tull is the founder, chairman, and chief executive officer of Legendary Entertainment, a media company that produces content for mainstream audiences.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Series A, Series C, Series B
- Geography: United States
Investor stats
- Total investments: 43
- Round size: Series A $12M–$250M; Series B $40M–$163M; Series C $50M–$320M
- Lead/follow: 51% lead, 49% follow
Portfolio highlights
- Slate Auto — We built it. You make it. A simple, affordable personalized truck (or SUV, your call). Put down a deposit today and lock in your delivery timing.
- Re:Build — Re:Build Manufacturing helps organizations move from concept to full-scale production by uniting design, engineering, and manufacturing to bring innovative products to market.
- Colossal Biosciences — The science of genetics. The business of discovery.
Daniel Curran is the Founder and CEO at CustEx.com.
Show more...Investment focus
- Industry: E-Commerce, Software, Internet
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Brazil
Investor stats
- Total investments: 145
- Round size: Seed $600k–$5M; Series A $3.6M–$23M; Series B $2.3M–$50M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- RentoMojo — RentoMojo is an online furniture rental platform that was incorporated in November 2014.It currently operates in Bangalore, Pune, Mumbai, Hyderabad, Chennai, Delhi, Gurgaon and Noida.RentoMojo was founded by Geetansh Bamania, an ex-IITM, in November 2014 in India. Like many other young working professionals, he was living in rented apartments,working long hours and found it inconvenient to equip the house with furniture when he moved. RentoMojo was developed to provide an alternative to buying and selling furniture in rental properties.
- Shred Video — Make awesome GoPro movies from raw footage in seconds. Download now on the Mac App Store! http://t.co/huKZsX8RBY
- GC Plus — Find Your Next Home Service Expert With Ease
Brian Armstrong is the CEO and Co-Founder of Coinbase. He previously worked at Airbnb.com as a Technical Product Manager. Brian Armstrong attended Rice University.
Show more...Investment focus
- Industry: Biotechnology, Payments, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United States, Brazil, Libya
Investor stats
- Total investments: 19
- Round size: Seed $2M–$25M; Series A $13M–$30M; Series B $45M–$130M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Brain Co. — AI platform and applications for the world's most important institutions
- NavigateAI — An AI copilot for every person in the field. NavigateAI upskills and coaches your team, runs real-time quality control, manages the project in the background, and provides expert knowledge, instantly.
- Preventive — Preventive mission is to determine whether the newest generation of gene editing technologies can be used safely and responsibly to correct devastating genetic conditions for future children.
Evan Cheng Co-founder & CEO at Mysten Labs. He attended Syracuse University.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Biotechnology
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Australia
Investor stats
- Total investments: 27
- Round size: Seed $120k–$5.8M; Pre-Seed $150k–$10M; Series A $3M–$18M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Jarsy — Pre-IPO Reimagined. Access + Research + Community.
- Kontigo — We help underbanked gig workers in Latam build credit and access group financing where small groups of family or friends lend and save money together. Users can validate their income from multiple sources such as gig apps, catalog sales, and open finance (Uber, Rappi, Didi, Indriver, Avon, and all major banks). After verifying the income wedirectly offer them group savings and group loans, without leaving WhatsApp, their primary messaging app.
- Kite AI — Building Agentic Payment Infrastructure Backed by @PayPal Ventures and @Generalcatalyst Kite Agent Passport: https://t.co/qw13oC6l3z
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Bill Gates is the Co-chair of Bill and Melinda Gates Foundation. He attended Harvard University.
Show more...Investment focus
- Industry: Energy, Biotechnology, Renewable Energy
- Stage:Series C, Series A, Series B
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 95
- Round size: Series A $12M–$105M; Series B $14M–$161M; Series C $14M–$135M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Koloma — Koloma is revolutionizing clean energy by harnessing naturally occurring hydrogen from deep within the Earth.
- TerraPower — Leading innovations in nuclear applications for reactor and storage technology, while advancing methods to transform the fight against cancer.
- Lucy Therapeutics — Lucy Therapeutics, a Boston-based biotech with a unifying mitochondrial platform, is developing small molecule treatments for neurological diseases.
Anne Wojcicki is the Co-Founder and CEO of 23andMe. She previously worked at Passport Capital as a Healthcare Analyst. Anne Wojcicki attended Yale University.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 64
- Round size: Seed $1M–$12M; Series A $7M–$70M; Series B $19M–$63M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- World Labs — World Labs is an AI startup that can analyze visual data with comprehension akin to a person's, a substantial advancement above existing capacities.
- The Invention Network — ScaleIP is an IP business intelligence platform that helps companies monetize IP.
- Clair Health — Clair Health is building the first noninvasive wearable continuous hormone monitor. Track estrogen, progesterone, LH, FSH, and PdG in real-time. Join the Clair Health waitlist.
Mark Cuban is the founder of Fireside, Chairman and Founding Partner of AXS TV, and the Owner of Dallas Mavericks. He previously worked at Broadcast.com as a Co-Founder. Mark Cuban attended the Indiana University Bloomington.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Blockchain
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 211
- Round size: Seed $600k–$9M; Series A $3.2M–$23M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Payam Music — Payam Music is where students fall in love with piano. Not only do they have fun but they win competitions. Endorsed by composer Hans Zimmer. Sign up for a trial in-person or online lesson!
- Kind Designs — Kind Designs is a trusted 3D Printed seawall contractor in Miami offering custom seawall construction, shoreline protection, erosion control solutions.
- The Athletics — The Athletics franchise is a professional spectator sports organization that operates a Major League Baseball club. The company manages athletic team rosters, player scouting, talent development, and medical staff for its baseball operations. It coordinates live event production, stadium technology, corporate sponsorships, and ticket saleslogistics for professional games. Additionally, the business oversees regional television, radio, and streaming broadcast infrastructure to distribute sports media content.
Fred Ehrsam is the Co-Founder of Paradigm.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Series A, Series C
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 54
- Round size: Seed $1M–$12M; Series A $7M–$70M; Series C $65M–$300M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- The Interaction Company of California — The proactive AI assistant in your iMessage, WhatsApp, and more. Texts like a human, really knows you, and integrates with your life in dozens of ways.
- Chai Discovery — Building frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules.
- Arcadia Medicine — Arcadia Medicine is a biotechnology company that creates psychedelic medicine to treat mental health issues.
Benjamin Kong is a Canadian investor backing early-stage transformative startups in Space, Biotech, Life Sciences, AI, Longevity, and Blockchain. He started investing in 2014 and has since funded over 50 startups and 3 VC funds. Recent early stage investments include Luminous Computing, Orbit Fab, Relativity Space, Swarm, TransAstra, RadianAerospace, Volumetric, OISIN, OncoSenX, Aegis BioDefense, Excision Biotherapeutics, MAIA Biotechnology, Ashvattha Therapeutics, ZenGo, Coinbase, Algorand, Oasis Labs, Arweave.
Show more...Investment focus
- Industry: Biotechnology, Blockchain, Cryptocurrency
- Stage:Seed, Pre-Seed
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 17
- Round size: Seed $750k–$8.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Radian — Radian Aerospace (Radian) is disrupting the aerospace industry with a next generation aerospace vehicle that is the world’s first fully reusable horizontal takeoff and landing, single-stage to orbit spaceplane, delivering people and light cargo to low earth orbit (LEO) and multiple terrestrial destinations with aircraft-like operations.
- MAIA Biotechnology — MAIA Biotechnology is an immuno-oncology company that focuses on developing first-in-class drugs with novel mechanisms.
- Excision BioTherapeutics — Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Edward Lando is the founder of Pareto Holdings. He previously worked at Horizons School of Technology as a co-founder. Edward Lando attended the Wharton School.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 478
- Round size: Seed $975k–$7M; Pre-Seed $125k–$3.4M; Series A $5.5M–$37M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- Humera — Humera - AI CAPTCHA That Knows You're Human
- Allonic — Allonic is a robotics hardware company pioneering 3D Tissue Braiding, a new manufacturing platform for producing integrated, compliant, bio-inspired robotic bodies through a single, fully automated production process. By eliminating assembly-heavy designs and supply-chain complexity, Allonic enables significantly faster iteration, lower costs, andsafer, more dexterous robots to be built. Originally founded from Hungary and operating internationally with a US HQ and a growing team of 15, Allonic is building the hardware foundation for the next generation of intelligent machines.
- Heywa Labs — Heywa Labs develops Generative UX (GenUX), an AI-driven interface layer that creates dynamic, adaptive user experiences beyond static text or links. Their flagship app, Heywa, delivers visual, tappable "stories" of cards for tasks like cooking, travel, fitness, and DIY, reconfiguring in real-time based on user interactions.
Erik Peterson is the Founder at DormTrader.
Show more...Investment focus
- Industry: Software, SaaS, Mobile
- Stage:Seed, Equity Crowdfunding, Series A
- Geography: United States, Canada, Algeria
Investor stats
- Total investments: 60
- Round size: Seed $150k–$4.5M; Series A $4M–$20M; Equity Crowdfunding $69k–$4.9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
- Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
- Altay Therapeutics — Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.
Darian Shirazi is the Managing Partner of Gradient.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Germany, Canada
Investor stats
- Total investments: 185
- Round size: Seed $2M–$10M; Series A $6.3M–$30M; Series B $22M–$73M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- SolveAI —
- Rowspace — Specialized intelligence for investors. Compound your firm's edge. We're hiring!
- Harmattan AI — Building the Future of Autonomous Warfare.
Alec Nielsen is the Founder & CEO at Asimov.
Show more...Investment focus
- Industry: Biotechnology, Biopharma, Medical
- Stage:Seed, Pre-Seed
- Geography: United States, Germany
Investor stats
- Total investments: 6
- Round size: Seed $3M–$16M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cache — Biomolecules are the next bits of the 21st century. So we're developing the first wet operating system for storing, accessing, and computing biomolecules at scale to make them widely accessible and useful. We're enabling the storage and access to the whole data universe—digital and biological—forever so that we don't have to deleteor dispose of anything ever again.
- Lamin — Lamin provides an open data platform for biology, enabling tracked data management, streamlined collaboration, and learning at scale.
- General Proximity — General Proximity is a pioneering future-oriented proximity medicine that envisions the future of medicine.
Cory Levy is the Founder of Z Fellows. He previously worked at DoSomething.org as a Board Member. Cory attended University of Illinois Urbana-Champaign, where he took Computer Science.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Advertising
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 75
- Round size: Seed $1.1M–$11M; Pre-Seed $200k–$3.3M; Series A $14M–$72M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Wander — Never book a bad vacation home again. Every Wander comes with hotel-grade amenities, inspiring views, pristine cleaning and 24/7 concierge service.
- Pilgrim — Pioneering a biologically enhanced future for humanity.
- Swish Robotics — Embodied Intelligence for the Home
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Eric Kwan - Co-Founder & Managing Partner @ Locus Ventures
Show more...Investment focus
- Industry: Software, FinTech, E-Commerce
- Stage:Seed, Pre-Seed
- Geography: United States, India, Canada
Investor stats
- Total investments: 55
- Round size: Seed $1M–$9.5M; Pre-Seed $125k–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Treinta — Treinta powers 7 million SMBs across the US and Latin America with simple finance, inventory, and sales tools.
- Ferveret — Ferveret develops liquid cooling technology for data centers and other infrastructure. Our company is backed by Y Combinator and MIT Media Lab's E14.
- Kriya AI is now Kalendar AI — Kalendar AI books new revenue on autopilot
Jack Abraham is based out of Florida and is the Chairman and Co-Founder of Indomo. Jack previously worked at TalkIQ as a Co-Founder and Investor. Jack Abraham attended The Wharton School.
Show more...Investment focus
- Industry: Health Care, Software, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United States, France, Hong Kong
Investor stats
- Total investments: 37
- Round size: Seed $1.2M–$20M; Series A $5M–$50M; Series B $17M–$100M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Healify — Healify is an AI-powered health coaching app for iPhone users that simplifies complex health data into personalized, actionable insights.
- Arago — Arago is an AI and computer hardware company developing an energy-efficient AI chip powered by light, and its associated software.
- Dorsia — Political Strategy & Consulting.
John D'Orazio is the Founder and Managing Partner of Proton Enterprises. He previously worked at SlideMoor as an Executive Partner. John D'Orazio attended Xavier University.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed, Equity Crowdfunding
- Geography: United States
Investor stats
- Total investments: 17
- Round size: Seed $245k–$1.3M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Twined — Have you ever spent hours trying to find that perfect product? Ever sifted through online reviews feeling like many of them were fake or written by people who weren't anything like you? These are the things that keep us up at night!Twined helps you easily discover unbiased product reviews and recommendations from real people that you canactually trust. We handpick our Tastemakers from around the web based on their knowledge and integrity.
- Vascular Genesis — A medical device company laying the foundation for vascular conduit replacement with its line of cell-free, synthetic scaffold products -- with self-healing capabilities that lower the risk of rejection, infection, and stenosis. Funding prior to formation: $2.5 million.
- Atreon Orthopedics — A medical device company building a line of orthopedic products that provide a structure for tissue growth and healing of sports medicine injuries including tendon ruptures/tears.
Todd Corenson - Founder @ Enlon
Show more...Investment focus
- Industry: Biotechnology, FinTech, SaaS
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: United States
Investor stats
- Total investments: 9
- Round size: Seed $1M–$4.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Solugen — Solugen's mission is to decarbonize the chemicals industry. Solugen combines synthetic biology with metal catalysis to make carbon negative chemicals at scale.Solugen's patented approach takes advantage of bio-inspired reactions to use plant material as a low-cost feedstock to produce novel products cost-competitive with thecompetition.
- HelixNano — Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. HelixNano is a Y Combinator and venture backed biotech startup. At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. We’re moving fast but thinking long-term. We’re alreadytesting COVID-19 vaccine candidates designed to be precise and safe. Our next goal is to create a vaccine that protects everyone not only from this virus, but all future coronaviruses.
- iMicrobes — We are a synthetic biology company on the mission to work with the world's largest companies to use new raw materials and recycle waste for chemical production, polymers, agriculture, and space exploration.
Esther Dyson - Founder @ Way to Wellville
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Series A
- Geography: United States, Canada, Russian Federation
Investor stats
- Total investments: 72
- Round size: Seed $270k–$4.3M; Series A $1.5M–$16M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- The Beans — The Beans offers a software application platform that creates personalized cash flow plans designed for its users. The Beans is Simplifying the path to financial balance through design and technology so that people can focus on what they love.
- NextSense — Introducing NextSense Smartbuds: EEG-powered earbuds that go beyond sleep tracking. Backed by science, Smartbuds provide real-time insights to help you achieve deeper, more restorative sleep. Comfortable, intuitive, and easy to use, Smartbuds empower you to wake up your best self.
- Openwater — OPENWATER - THE FUTURE OF NEURAL DIAGNOSTICS IN THE PALM OF YOUR HAND.
Timothy A. Springer is the Founder of Institute for Protein Innovation.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B, Post-IPO Equity
- Geography: United States, Canada
Investor stats
- Total investments: 12
- Round size: Series A $52M–$101M; Series B $15M–$121M; Post-IPO Equity $60M–$130M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Seismic Therapeutic — Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using its IMPACT™ platform, the company is addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements ofbiologics drug discovery – structural biology, protein engineering, and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases.
- Selecta Biosciences — Selecta Biosciences is a biopharmaceutical company developing the first generation of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Their proprietary product platform technology combines recent advances in immunobiology with cutting-edge nanotechnology to develop targeted immunomodulatory nanoparticles.Itwas founded in 2008 and is headquartered in Watertown, Massachusetts.
- Cartesian Therapeutics — Cartesian Therapeutics is a biotechnology company developing potent, safer cell and gene therapies for cancer and autoimmune diseases
Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 132
- Round size: Seed $150k–$18M; Series A $7.2M–$36M; Series B $19M–$120M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- Key AI — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
- Catena Labs — Catena is a product studio where we transform complex computing advancements into accessible, practical tools for users and developers. Leveraging AI and web3 technology our aim is to turn innovative ideas into real-world applications that are easy to use.
- Odyssey — Odyssey is an AI lab pioneering general world models: causal, multimodal systems that learn to understand and simulate the world.
Nat Turner is based out of New York, New York, and is the CEO and Chairman of Collectors. Nat previously worked at OneOncology as a board member. Nat Turner attended the Wharton School of the University of Pennsylvania.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Series A, Series B
- Geography: United States, China, Colombia
Investor stats
- Total investments: 78
- Round size: Seed $1.5M–$6.3M; Series A $3M–$25M; Series B $5M–$36M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CollX — Snap photos of them and instantly get the current market price. Add them to your collection and track your overall portfolio value.
- Collectors — The infrastructure that powers trust, security, and opportunity in collectibles.
- Iterative Health — Iterative Health is a healthcare technology and services company that focuses on accelerating clinical research to improve patient outcomes through innovative approaches. The company transforms gastrointestinal (GI) care by utilizing AI-driven clinical trials and diagnostics, significantly enhancing access to vital treatments.
David is a Partner of Amplify Partners and co-founder of Chartio.com.Before joining Amplify Partners, David spent time as both a venture-backed entrepreneur and an early-stage investor. He began his career in technology as the co-founder and CEO of Chartio.com, a pioneering provider of cloud-based data visualization and analytics. He wassubsequently part of the founding team at Patients Know Best, one of the world’s leading cloud-based personal health record companies. David has been a prolific investor and advisor to entrepreneurs. He has personally invested in more than 50 early-stage companies, including Zymergen, Skycatch, Caribou Biosciences, Rigetti Computing, Casetext, Ginkgo Bioworks, Function of Beauty, Cruise Automation, and Bugcrowd. In addition, he currently serves on the advisory council of Bayes Impact, a nonprofit organization that deploys data science to solve important social challenges.He attended Brown University.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A, Angel
- Geography: United States
Investor stats
- Total investments: 38
- Round size: Seed $1.2M–$4M; Angel $500k–$2.2M; Series A $2.7M–$23M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Astranis — Four billion people still have no internet access. Astranis is here to change that. We're making small satellites for geostationary orbit, recently signed a contract to triple the satellite internet capacity of Alaska, and raised our Series A from Andreessen Horowitz.
- Ginkgo Bioworks — Build autonomous labs to accelerate biotech R&D. Program biology like software. Run experiments on our cloud lab or build your own. Trusted by 130+ customers.
- Bagaveev Corporation — BEJO88 menghadirkan login situs slot Thailand gacor dengan server paling kenceng saat ini yang cocok untuk kamu yang ingin bermain tanpa delay dan cepat menang tanpa pusing ngelag ngelag.
Max Levchin is the Founder and CEO of Affirm. He previously worked at the Consumer Financial Protection Bureau as an Advisory Board Member. Max Levchin attended the University of Illinois Urbana-Champaign.
Show more...Investment focus
- Industry: FinTech, Financial Services, Software
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 115
- Round size: Seed $1.3M–$10M; Series A $4M–$27M; Series B $7.5M–$50M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Bland AI — Transform your enterprise communication with Bland AI. Automate inbound and outbound phone calls using AI that sounds human. Perfect for sales, customer support, and operations with customizable voices and seamless integrations.
- CoPilot — CoPilot is pioneering Assisted Commerce for big-ticket purchases – starting with cars. You are the one spending the money - shouldn't you have an expert on your side? We founded CoPilot to make that a reality. For the average car buyer, who is not a car expert or enthusiast, car shopping can be a time consuming, frustrating process that leavespeople feeling alone and disadvantaged. CoPilot is changing this dynamic. Like a trusted friend who is knowledgeable about cars, knows where to look and what to buy, CoPilot provides car shoppers with an expert partner who empowers them to discover the perfect car at the best possible price with ease and confidence.
- Black Ore Technologies — Black Ore's Tax Autopilot is the first AI tax platform for CPAs, offering complete 1040 tax preparation automation to tax professionals, so they can focus on growing their firm.
Biotech Angel investor funding in United States at a glance
Stats across 1.4k deals from 1.6k investors.
Access all 1557 angel investors in United States Biotech startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech Angel Investors in United States investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 1557 angel investors investing in United States Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!